glp-1 and neuroinflammation A schematic representation of the mechanism of glucagon-like peptide-1 GLP-1R as a potential link

The brand doesnt highlight required lab work or ongoing metabolic monitoring, so patients who want a deep clinical dive or have a complicated medical history may find it lacking

A new clinical study from the Mayo Clinic, published in Anesthesia & Analgesia (2026) , provides critical insights into how these medications influence gastric physiology and potentially increase the risk of pulmonary aspiration during anesthesia

24 hours after taking certain diabetes medications (like insulin or sulfonylureas, if youre using them together with GLP-1s) Between meals, when blood sugar naturally dips During or after exercise, especially if you havent eaten enough beforehand After dose changes, as your body adapts to stronger appetite-suppressing effects During rapid weight loss or dietary changes, when your energy intake is lower than usual Whos at higher risk

In the SURMOUNT-1 trial, tirzepatide 15 mg weekly achieved 20.9% WL over 72 weeks (vs